James P. Kelly

2016 - Vanda Pharmaceuticals

In 2016, James P. Kelly earned a total compensation of $2.2M as Executive Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, a 91% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$202,800
Option Awards$548,800
Salary$390,000
Stock Awards$1,015,000
Other$32,429
Total$2,189,029

Kelly received $1M in stock awards, accounting for 46% of the total pay in 2016.

Kelly also received $202.8K in non-equity incentive plan, $548.8K in option awards, $390K in salary and $32.4K in other compensation.

Rankings

In 2016, James P. Kelly's compensation ranked 4,482nd out of 14,075 executives tracked by ExecPay. In other words, Kelly earned more than 68.2% of executives.

ClassificationRankingPercentile
All
4,482
out of 14,075
68th
Division
Manufacturing
1,583
out of 5,489
71st
Major group
Chemicals And Allied Products
483
out of 1,895
75th
Industry group
Drugs
354
out of 1,538
77th
Industry
Pharmaceutical Preparations
277
out of 1,176
76th
Source: SEC filing on April 27, 2017.

Kelly's colleagues

We found four more compensation records of executives who worked with James P. Kelly at Vanda Pharmaceuticals in 2016.

2016

Mihael Polymeropoulos

Vanda Pharmaceuticals

Chief Executive Officer

2016

Gian Reverberi

Vanda Pharmaceuticals

Senior Vice President, Chief Commercial Officer

2016

Richard Gulino

Vanda Pharmaceuticals

General Counsel

2016

Paolo Baroldi

Vanda Pharmaceuticals

Chief Medical Officer

News

You may also like